Cash Flow Statement
Growth Metrics

Opko Health (OPK) EPS (Weighted Average and Diluted) (2016 - 2026)

Opko Health filings provide 16 years of EPS (Weighted Average and Diluted) readings, the most recent being -$0.07 for Q1 2026.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 30.0% to -$0.07 in Q1 2026 year-over-year; TTM through Mar 2026 was -$0.27, a 285.71% decrease, with the full-year FY2025 number at -$0.3, down 275.0% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$0.07 in Q1 2026 for Opko Health, down from -$0.04 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.03 in Q3 2024 to a low of -$0.19 in Q2 2025.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.08 (2022), compared with a mean of -$0.07.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): skyrocketed 127.27% in 2024 and later crashed 1800.0% in 2025.
  • Opko Health's EPS (Weighted Average and Diluted) stood at -$0.11 in 2022, then rose by 18.18% to -$0.09 in 2023, then soared by 111.11% to $0.01 in 2024, then crashed by 500.0% to -$0.04 in 2025, then plummeted by 75.0% to -$0.07 in 2026.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$0.07 (Q1 2026), -$0.04 (Q4 2025), and $0.03 (Q3 2025) per Business Quant data.